These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 22486168)
1. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease. El-Hussuna A; Andersen J; Bisgaard T; Jess P; Henriksen M; Oehlenschlager J; Thorlacius-Ussing O; Olaison G Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168 [TBL] [Abstract][Full Text] [Related]
2. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients. Syed A; Cross RK; Flasar MH Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144 [TBL] [Abstract][Full Text] [Related]
3. The impact of preoperative biologic therapy on anastomotic complications after surgery for Crohn's disease. Yamamoto T; Shiraki M Scand J Gastroenterol; 2012 Dec; 47(12):1521-2. PubMed ID: 22809295 [No Abstract] [Full Text] [Related]
4. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354 [TBL] [Abstract][Full Text] [Related]
5. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study. Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161 [TBL] [Abstract][Full Text] [Related]
6. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy. Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease. Bafford AC; Powers S; Ha C; Kruse D; Gorfine SR; Chessin DB; Bauer JJ J Clin Gastroenterol; 2013 Jul; 47(6):491-5. PubMed ID: 23090048 [TBL] [Abstract][Full Text] [Related]
8. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease. Shental O; Tulchinsky H; Greenberg R; Klausner JM; Avital S Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease. Kanazawa A; Yamana T; Okamoto K; Sahara R Dis Colon Rectum; 2012 Sep; 55(9):957-62. PubMed ID: 22874602 [TBL] [Abstract][Full Text] [Related]
10. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates? Canedo J; Lee SH; Pinto R; Murad-Regadas S; Rosen L; Wexner SD Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715 [TBL] [Abstract][Full Text] [Related]
11. Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage. Klein M Dan Med J; 2012 Mar; 59(3):B4420. PubMed ID: 22381097 [TBL] [Abstract][Full Text] [Related]
12. A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery. Zuo L; Li Y; Wang H; Zhu W; Zhang W; Gong J; Li N; Li J Dis Colon Rectum; 2015 Aug; 58(8):775-81. PubMed ID: 26163957 [TBL] [Abstract][Full Text] [Related]